No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters

British Journal of Cancer

Volumn 76, Issue 8, 1997, Pages 992-1000

  Edwards, S M ^a   Dearnaley, D P ^a,b   Ardern Jones, A ^b   Hamoudi, R A ^a   Easton, D F ^c   Ford, D ^a   Shearer, R ^b   Dowe, A ^b   Eeles, R A ^a,b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Gene MXI1; Prostate cancer; Susceptibility

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SUSCEPTIBILITY; CHROMOSOME 10Q; CLINICAL ARTICLE; DIMERIZATION; GENE MUTATION; GENE SEQUENCE; GERM LINE; HETEROZYGOSITY LOSS; HUMAN; MALE; ONCOGENE; PRIORITY JOURNAL; PROSTATE CANCER; SIBLING; TUMOR SUPPRESSOR GENE;

EID: 0030865628     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.498     Document Type: Article

References (21)

1. Buttyan R, Sawczuk IS, Benson MC et al (1987) Enhanced expression of the c-myc proto-oncogene in high grade human prostate cancers. Prostate 11: 327-337
2. Steinberg GD, Carter BS, Beaty TH et al (1990) Family history and the risk of prostate cancer. Prostate 17: 337-347
3. Carter BS, Beaty TH, Steinberg GD, Childs B and Walsh PC (1992) Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 89: 3367-3371
4. Coleman MP, Esteve J, Damiecki P et al (1993) Trends in cancer incidence and mortality. IARC1 21: 232-242
5. Eagle LR, Yin X, Brothman AR, Williams BJ, Atkin NB and Prochownik EV (1995) Mutation at the MXII gene in prostate cancer. Nature Genet 9: 249-255
6. Easton DF and Peto J (1990) The contribution of inherited predisposition to cancer incidence. Cancer Surv 9: 395-416
7. Eeles RA (1995) The genetics of prostate cancer in cancer biology and medicine. In The Genetics of Cancer, Vol. 4. Waring M and Ponder BAJ (eds), pp. 69-70. Kluwer Academic Press
8. Eeles RA, and Cannon-Albright, LA (1996) Familial prostate cancer and its management in genetic predisposition to cancer. In: Genetic Predisposition to Cancer. Eeles RA, Ponder BAJ, Easton DE and Horwich AJ (eds), p. 332. Chapman & Hall: London
9. Goldgar DE, Easton DF, Cannon-Albright, LA and Skolnick, MH (1994) A systematic population based assessment of cancer risk in first degree relatives of cancer probands. J Natl Cancer Inst 86: 1600-1608
10. Gray IC, Phillips SMA, Lee SJ, Neoptolemos JP, Weissenbach J and Spurr NK (1995) Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res 55: 4800-4803
11. Grönberg H, Damber, L and Damber JE (1996) Familial prostate cancer in Sweden. Cancer 71: 138-143
12. Hamoudi RA, De Schouwer PJJC, Yuille MAR and Dyer, MJS (1996). Improved direct fluorescent automated sequencing of PCR products. Trends Genet (in press)
13. Kato GJ, Barrett J, Villa-Garcia M and Dang CV (1990) An amino acid terminal c-myc domain required for neoplastic transformation activates transcription. Mol Cell Biol 10: 5914-5920
14. Knudson, AG (1985) Hereditary cancer, oncogenes and antioncogenes. Cancer Res 45: 1437-1443
15. Kunkel LM, Smith KD, Boyer SH, Borgaonker DS, Wachtel SS, Miller OJ, Breg WR, Jones HWJ and Rary JM (1977) Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 74: 1245-1249
16. Miller, SA, Dykes, DD and Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215
17. Mulligan LM, Kwok JBJ, Healey CS et al (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363: 458-460
18. Murre C, McCaw, PS and Baltimore D (1989) A new DNA binding and dimeration motif in immunoglobulin enhancer binding, daughterless, MyoD and myc proteins. Cell 56: 777-783
19. OPCS (1993). HMSO.
20. Smith JR, Freije D, Carpten JD et al (1996) Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 274: 1371-1373
21. Zervos A, Gyuris J and Brent R (1993) MXI1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72: 223-232